The good news is that vaccines are on their way, to combat the Covid-19 strain of coronavirus, the bad news is that for the foreseeable future we’ll have to be vaccinated every year.
IGTV’s Jeremy Naylor talks to Cathal Friel, CEO of Open Orphan, an viral testing company that is watching how the picture will develop for those pharmaceutical companies that are in the throes of developing anti-virals. Those treatments, it is hoped, will enable us to return to normality. But what then? Which drug is going to be the preferred option?